Pentwater Capital Management LP, 10% Owner at Tobira Therapeutics, Inc. (TBRA), bought 24,538 shares at $39.49 ($969K) on 2016-09-29, disclosed to the SEC on 2016-09-30.
Open-market purchase of $969k TBRA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.49 | 6,500 | $257K | 26.5% |
| 2 | $39.49 | 9,019 | $356K | 36.8% |
| 3 | $39.49 | 9,019 | $356K | 36.8% |
| Total | $39.49 avg | 24,538 | $969K | 100% |
| Filing → |
| CAR | SELL | 2026-04-28 | $223.1M | — | Filing → |
| CAR | BUY | 2026-02-24 | $80.1M | — | Filing → |
| TBRA | BUY | 2016-11-02 | $628K | — | Filing → |